Get the Stockscreener App
4.25
0.47%
-0.02
After Hours:
4.28
0.03
+0.71%
Applied Dna Sciences Inc stock is traded at $4.25, with a volume of 28,695.
It is down -0.47% in the last 24 hours and down -17.48% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$4.27
Open:
$4.24
24h Volume:
28,695
Relative Volume:
0.22
Market Cap:
$3.27M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-7.7273
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
+0.47%
1M Performance:
-17.48%
6M Performance:
-96.90%
1Y Performance:
-98.43%
1-Day Range:
$4.1608
$4.30
1-Week Range:
$4.04
$4.64
52-Week Range:
$4.04
$2,655.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
4.25 | 2.17M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
462.39 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.76 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
652.11 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.13 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
180.09 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application - ACCESS Newswire
Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Pocono Record
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Barnstable Patriot
Applied DNA Sciences Inc expected to post a loss of $37.50 a shareEarnings Preview - TradingView
When is Applied DNA Sciences Inc. stock expected to show significant growthExceptional market performance - Jammu Links News
Is it the right time to buy Applied DNA Sciences Inc. stockGet timely market insights for better trades - Jammu Links News
Is Applied DNA Sciences Inc. a growth stock or a value stockDynamic profit expansion - Jammu Links News
What is the dividend policy of Applied DNA Sciences Inc. stockAchieve rapid portfolio growth with expert guidance - Jammu Links News
What are analysts’ price targets for Applied DNA Sciences Inc. in the next 12 monthsHigh-yield market plays - Jammu Links News
What are Applied DNA Sciences Inc. company’s key revenue driversSuperior profit margins - Jammu Links News
What makes Applied DNA Sciences Inc. stock price move sharplyFree Investment Community - Jammu Links News
How does Applied DNA Sciences Inc. compare to its industry peersDiscover stocks with massive upside potential - Jammu Links News
How many analysts rate Applied DNA Sciences Inc. as a “Buy”Get high-impact stock recommendations now - Jammu Links News
Why is Applied DNA Sciences Inc. stock attracting strong analyst attentionDiscover hidden gems in the stock market - Jammu Links News
Is Applied DNA Sciences Inc. stock overvalued or undervaluedEarnings Report Outlook For 2025 - Jammu Links News
Is Applied DNA Sciences Inc. still worth holding after the dipNews Based Entry Opportunity Alerts Detected - metal.it
Key resistance and support levels for Applied DNA Sciences Inc.Daily Momentum Screener With Alerts Launched - metal.it
Published on: 2025-07-30 01:33:12 - metal.it
Momentum Screeners Rank Applied DNA Sciences Inc. in Top 5 Today - metal.it
Published on: 2025-07-29 21:53:18 - beatles.ru
How did APDN's revenue and expenses trend in Q1 2025? - AInvest
Why Applied DNA Sciences Inc. stock attracts strong analyst attentionBreakout Momentum Picks With Protection Outlined - metal.it
What are the technical indicators suggesting about Applied DNA Sciences Inc.Post Market Opportunities For Consistent Profits - Jammu Links News
How does Applied DNA Sciences Inc. generate profit in a changing economyUnprecedented profits - Jammu Links News
Applied DNA Sciences Inc. Stock Analysis and ForecastMarket-beating performance - PrintWeekIndia
Is Applied DNA Sciences Inc. a good long term investmentFree Trend-Following Techniques - PrintWeekIndia
Will Applied DNA Sciences Inc. stock split in the near futureRobust investment performance - Jammu Links News
What institutions are buying Applied DNA Sciences Inc. stock nowConsistent double returns - Jammu Links News
What drives Applied DNA Sciences Inc. stock priceDouble or triple returns - Autocar Professional
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):